Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-β1 under the control of dietary xylan

Zaed Hamady, Nigel Scott, Mark D. Farrar, Meenu Wadhwa, Paula Dilger, Terence R. Whitehead, Robin Thorpe, Keith T. Holland, Peter J.A. Lodge, Simon R. Carding

Inflammatory Bowel Diseases · 2010 · 103 citations · 40 references

Abstract

This novel drug delivery system has potential for the targeted and controlled delivery of TGF-β(1) and other immunotherapeutic agents for the long-term management of various bowel disorders.

References

40